Home/Primo Biotechnology/Ya‑Yao Huang, Ph.D.
YH

Ya‑Yao Huang, Ph.D.

Founder & CEO

Primo Biotechnology

Therapeutic Areas

Primo Biotechnology Pipeline

DrugIndicationPhase
Primo‑CR‑001Colorectal CancerPhase 1
PRIMO‑SOL‑ASolid TumorsPreclinical
PRIMO‑TB161‑001Various Solid TumorsPreclinical
Fludeoxyglucose F‑18PET Imaging (Oncology)Commercial